GlobeNewswire 4/23/2025 Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Cat...
TeleTrader 4/8/2025 Europe surges at close on tariff relief hopes
GlobeNewswire 3/31/2025 Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Upda...
GlobeNewswire 3/20/2025 MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
GlobeNewswire 2/25/2025 Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire 2/12/2025 Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
GlobeNewswire 2/12/2025 Heineken Holding N.V. reports 2024 full year results
GlobeNewswire 8/26/2024 Simtra BioPharma Solutions Appoints Dr. Lidia Serina as Head of Development Sciences
GlobeNewswire 8/23/2024 Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, G...
GlobeNewswire 8/8/2024 Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/6/2024 Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/6/2024 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 8/1/2024 Galapagos reports half-year 2024 financial results and provides second quarter business update
GlobeNewswire 6/14/2024 Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire 6/13/2024 Repligen Announces CEO Transition Plan
GlobeNewswire 5/30/2024 Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire 5/15/2024 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire 5/14/2024 Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 5/9/2024 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire 5/8/2024 Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8/2024 Maravai LifeSciences Reports First Quarter 2024 Financial Results
GlobeNewswire 4/4/2024 Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire 4/4/2024 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 3/7/2024 MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
GlobeNewswire 2/27/2024 Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update